A multicenter, randomized, placebo controlled, multiple-dose, safety and pharmacokinetic study of AIT-082 (Neotrofin) in mild Alzheimer's disease patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples